Schedule 13G ownership disclosure

LUMOS PHARMA INC

Common Stock · CUSIP: 55028X109

Event date: 2024-12-31

Filing-level shares
Unavailable
Percent of class
0%
  • Private Advisor Group, LLC

    Shares: Unavailable · Class: 0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001085146-25-001315
Form type
SCHEDULE 13G/A
Filer
LUMOS PHARMA, INC.
CIK
CIK 1126234
Filed
Feb 13, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub